Twist Bioscience Corporation (TWST), a company specializing in synthetic DNA, announced its financial results for the third quarter of fiscal 2024. The company utilizes its silicon platform to provide high-quality synthetic DNA to its customers. The financial results and business highlights cover the period ending June 30.
The report showcases Twist Bioscience's continued success in the synthetic DNA market. With a focus on enabling customers to succeed, the company's innovative approach to DNA synthesis has positioned it as a leader in the industry. The third-quarter results reflect Twist Bioscience's commitment to delivering quality products and services.
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.